Rovio Entertainment Corp.: Managers' transactions - Marjo

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
84
Rovio Entertainment Corp.: Managers' transactions - Marjo Kuosmanen

Rovio Entertainment Corporation: Managers' transactions

ROVIO ENTERTAINMENT CORPORATION          MANAGERS' TRANSACTIONS     STOCK EXCHANGE RELEASE    6 August 2018  5:50 p.m. EET

Rovio Entertainment Corporation: Managers' transactions

Person subject to the notification requirement

Name:                                 Marjo Kuosmanen

Position:                              Other senior manager

Issuer:                                 Rovio Entertainment Oyj

LEI:                                     743700H95H3OPXDV6568

REFERENCE NUMBER:    743700H95H3OPXDV6568_20180806093824_4

Notification type:                 INITIAL NOTIFICATION

Transaction date:             3 August 2018

Venue:                             Outside a trading venue

Instrument type:              FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT

Instrument name:            Rovio Entertainment Corporation's option right 2018A

Nature of the transaction: ACCEPTANCE OF A STOCK OPTION

Transaction Details

Volume: 30 000 Unit price: 0

Aggregated transactions

Volume: 30 000 Volume weighted average price: 0

ROVIO ENTERTAINMENT CORPORATION

Mikko Setälä

EVP, Investor Relations

For additional information:

Mikko Setälä

EVP, Investor Relations

tel. +358 400 607 437

www.rovio.com

Distribution: NASDAQ Helsinki, main media, www.rovio.com

About Rovio:

Rovio Entertainment Corporation is a global entertainment company that creates, develops and publishes mobile games, which have been downloaded over 4 billion times. The Company is best known for the global Angry Birds brand, which started as a popular mobile game in 2009, and has since evolved from games to various entertainment and consumer products in brand licensing. Today, the Company offers multiple mobile games, animations and has produced The Angry Birds Movie, which opened number one in theatres in 50 countries and the sequel of which is planned to be released in 2019. Rovio is headquartered in Finland and the company's shares are listed on the main list of NASDAQ Helsinki stock exchange with the trading code ROVIO. ( www.rovio.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Lawsuit Against Everus Builds

Updated Category News Views 97

Investigation of Claims Against Everus Construction Group Faruqi & Faruqi, LLP, a well-respected national securities law firm, has initiated an investigation into potential claims associated with Everus Construction Group, Inc. (NYSE: ECG). The firm specializes in shareholder rights and is aiming to provide support to affected investors after concerning revelations about...

Continue Reading
Heilongjiang Forum 2025: Elevating Macao's Global Tourism Standing

Updated Category News Views 107

Global Tourism Economy Forum 2025: A Landmark Event The Global Tourism Economy Forum (GTEF) made its notable debut outside of Macao by hosting the 2025 edition in Heilongjiang province, China. This forum gathered influential figures from the tourism sector and various related industries, fostering discussions aimed at exploring new avenues for cooperation and growth....

Continue Reading
Nextracker and T1 Energy Collaboration Drives Solar Growth

Updated Category News Views 198

Nextracker and T1 Energy Join Forces to Strengthen Solar Production Nextracker Inc. (NASDAQ: NXT) has recently established a partnership with T1 Energy Inc. (NYSE: TE) aimed at revolutionizing solar manufacturing. This collaboration will see the integration of Nextracker's cutting-edge steel module frame technology into T1 Energy's upcoming solar manufacturing plant,...

Continue Reading
Nathan Ballentine Steps In as Regional VP at New American Funding

Updated Category News Views 175

New Leadership at New American Funding New American Funding (NAF), a prominent independent mortgage lender, has announced a significant appointment. Nathan Ballentine is joining the team as the Regional Vice President, where he will play a pivotal role in propelling growth and development within the state. His expertise will be crucial as the company seeks to deepen its...

Continue Reading
CSL Behring Secures Approval for ANDEMBRY® in Japan

Updated Category News Views 341

CSL Behring's Recent Approval for ANDEMBRY® CSL Behring has announced a significant medical milestone with the approval of ANDEMBRY® (garadacimab) subcutaneous (S.C.) injection 200mg pens in Japan. This groundbreaking therapy is a first-in-class monoclonal antibody specifically designed to inhibit activated Factor XII (FXIIa), a crucial initiator in the hereditary...

Continue Reading